Source: Eur Respir Monogr 2020; 87: 29-47
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Xuan Yao, Nikolaos I. Kanellakis. In vitro and in vivo laboratory models of pleural disease. Eur Respir Monogr 2020; 87: 29-47

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Development of in vitro assays to predict fibrogenesis and replace animal testing Source: Eur Respir J 2006; 28: Suppl. 50, 521s Year: 2006 In vitro and in vivo studies of nanoparticles and the lung Source: International Congress 2014 – Nanomaterials and respiratory health Year: 2014 Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum Source: Eur Respir J 2014; 44: 254-257 Year: 2014 3he MRI and an animal model of interstitial lung disease Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities Year: 2009 Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Molecular imaging of the progression of pulmonary fibrosis using animal models of disease Source: Eur Respir J 2006; 28: Suppl. 50, 605s Year: 2006 Modeling in vitro, ex vivo or in vivo? Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013 In vitro modelling of epithelia-fibroblast interactions in idiopathic pulmonary fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 PG19 In vitro models of the pulmonary epithelium: beyond simple culture Source: Milan 2017 - Educational material Year: 2017 LPA1 antagonist BMS-986278 for idiopathic pulmonary fibrosis: Preclinical pharmacological in vitro and in vivo evaluation Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 An in vivo comparison of two lung function systems Source: Eur Respir J 2005; 26: Suppl. 49, 177s Year: 2005 Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Progress in modelling acute lung injury in a pre-clinical mouse model Source: Eur Respir J 2012; 39: 1062-1063 Year: 2012 Preclinical models and imaging biomarkers of lung injury and disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020